Mediolanum International Funds’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.1M Sell
495,800
-17,988
-4% -$2.11M 0.55% 32
2026
Q1
$60.7M Sell
513,788
-402,061
-44% -$46.4M 0.64% 29
2025
Q4
$97.1M Buy
915,849
+18,561
+2% +$1.74M 0.97% 13
2025
Q3
$70.5M Buy
897,288
+246,759
+38% +$20.3M 0.74% 22
2025
Q2
$51.5M Sell
650,529
-209,747
-24% -$16.7M 0.62% 30
2025
Q1
$76.8M Sell
860,276
-94,660
-10% -$8.84M 1.06% 16
2024
Q4
$93.7M Buy
954,936
+179,836
+23% +$18.5M 1.22% 12
2024
Q3
$88M Buy
775,100
+102,517
+15% +$12.2M 1.22% 13
2024
Q2
$81.5M Sell
672,583
-21,542
-3% -$2.77M 1.33% 12
2024
Q1
$91.5M Buy
+694,125
New +$85.6M 1.49% 9

Other funds holding MRK

Mediolanum International Funds's MRK Position: Q2 2026 in Review

Mediolanum International Funds reduced its Merck (MRK) stake by 3.5% in Q2 2026, selling an estimated $2.11M and leaving 495,800 shares worth $64.1M. The position accounts for 0.55% of the portfolio, ranked #32.

Mediolanum International Funds first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $97.1M in Q4 2025. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mediolanum International Funds held 495,800 shares of Merck worth $64.1M as of Q2 2026.
  • Mediolanum International Funds sold 17,988 Merck shares in Q2 2026, an estimated $2.11M.
  • Merck made up 0.55% of Mediolanum International Funds's portfolio in Q2 2026, its #32 holding.
  • Mediolanum International Funds first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Merck position peaked at $97.1M in Q4 2025.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.